BioLineRx Ltd(NASDAQ:BLRX) 
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134...
Website: http://www.biolinerx.com
Founded: 2003
Full Time Employees: 42
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 0.84
H 0.84
L 0.76
C 0.81
V 266,976
10EMA 0.81
20EMA 0.81
60EMA 0.81
120EMA 0.81
250EMA 0.81